OSTEOPOROSIS TREATMENT MARKET ANALYSIS

Osteoporosis Treatment Market, By Drug Type (Bisphosphonates, Calcitonin, Hormone Therapy, Selective Estrogen Receptor Modulators, Parathyroid Hormone-Related Protein Analog, Others), By Route of Administration (Oral, Injectable, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

Published In : Apr 2024
Code : CMI1096
Pages :165
Formats :
Excel and PDF
Industry : Pharmaceutical

Market Challenge – Increasing Product Recall

The major factors that hinder growth of the global osteoporosis treatment market include product recalls and side effects associated with osteoporosis drugs such as pain in the joints, muscles, or bones, nausea, dizziness, etc. For instance, in April 2022, Macleods Pharmaceuticals Ltd., a pharmaceutical company, recalled 4,872 bottles of a drug used to treat or prevent osteoporosis, manufactured at Baddi (Himachal Pradesh), India due to failed content uniformity specifications.

Market Opportunity – Increasing Growth Strategies

Increasing adoption of inorganic growth strategies such as agreement is expected to offer lucrative growth opportunities over the forecast period. For instance, in February 2023, The World Health Organization (WHO) and the European Society for Clinical and Economic Aspects of Osteoporosis, Osteoarthritis and Musculoskeletal Diseases (ESCEO) signed an agreement to develop a strategic roadmap on bone health and ageing and advocate for a public health strategy to prevent fractures among older people.